electroCore, Inc. (ECOR)
Stock Price:
$1.57 USD
-0.10 (-5.99%)
Updated Oct 22, 2020 4:00 PM EDT - Market closed
After-hours: $1.63 +0.06 (3.82%) Oct 22, 7:05 PM
Key Info
| Market Cap |
69.91M |
| Revenue (ttm) |
2.84M |
| Net Income (ttm) |
-31.89M |
| Shares Out |
44.53M |
| EPS (ttm) |
-1.02 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Oct 22, 2020 |
| Last Price |
$1.57 |
| Previous Close |
$1.67 |
| Change ($) |
-0.10 |
| Change (%) |
-5.99% |
| Day's Open |
1.69 |
| Day's Range |
1.53 - 1.71 |
| Day's Volume |
486,929 |
| 52-Week Range |
0.32 - 3.30 |
More Stats
| Market Cap |
69.91M |
| Enterprise Value |
54.13M |
| Earnings Date (est) |
Nov 11, 2020 |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
44.53M |
| Float |
34.71M |
| EPS (basic) |
-1.05 |
| EPS (diluted) |
-1.02 |
| FCF / Share |
-0.81 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
945,193 |
| Short Ratio |
1.58 |
| Short % of Float |
2.72% |
| Beta |
1.77 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
24.57 |
| PB Ratio |
3.79 |
| Revenue |
2.84M |
| Operating Income |
-33.44M |
| Net Income |
-31.89M |
| Free Cash Flow |
-29.75M |
| Net Cash |
15.77M |
| Net Cash / Share |
0.35 |
| Gross Margin |
43.36% |
| Operating Margin |
-1,175.39% |
| Profit Margin |
-1,120.90% |
| FCF Margin |
-1,045.68% |
| ROA |
-50.22% |
| ROE |
-100.75% |
| ROIC |
-214.80% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (4)
| Buy |
3 |
| Overweight |
0 |
| Hold |
1 |
| Underweight |
0 |
| Sell |
0 |
Price Target
$3.38*
(115.29% upside)
Low
3.00
Current: $1.57
High
4.00
Target: 3.38
*Average 12-month price target from 4 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 |
|---|
| Revenue | 2.39 | 0.99 | 0.81 | 0.25 |
| Revenue Growth | 140.72% | 22.37% | 219.3% | - |
| Gross Profit | 1.23 | 0.41 | 0.29 | 0.13 |
| Operating Income | -46.09 | -54.55 | -25.64 | -15.01 |
| Net Income | -45.15 | -55.82 | -35.79 | -15.74 |
| Shares Outstanding | 29.38 | 29.26 | 308 | 151 |
| Earnings Per Share | -1.54 | -1.19 | - | -0.10 |
| Operating Cash Flow | -45.07 | -47.11 | -25.33 | -13.23 |
| Capital Expenditures | -0.07 | -0.28 | -0.15 | - |
| Free Cash Flow | -45.14 | -47.39 | -25.48 | -13.23 |
| Cash & Equivalents | 24.06 | 68.56 | 37.17 | 0.42 |
| Total Debt | 2.02 | - | - | 3.67 |
| Net Cash / Debt | 22.04 | 68.56 | 37.17 | -3.25 |
| Assets | 35.46 | 73.50 | 39.23 | 0.62 |
| Liabilities | 10.56 | 7.32 | 6.43 | 13.50 |
| Book Value | 24.26 | 65.55 | -90.07 | -61.45 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
electroCore, Inc. |
| Country |
United States |
| Employees |
51 |
| CEO |
Daniel S. Goldberger |
Stock Information
| Ticker Symbol |
ECOR |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Medical Instruments & Supplies |
| Unique Identifier |
NASDAQ: ECOR |
| IPO Date |
June 22, 2018 |
Description
electroCore, a commercial stage medical device company, engages in the development and commercialization of a range of patient administered non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld delivery system for multi-year use prescribed on a monthly basis. The company was founded in 2005 and is headquartered in Basking Ridge, New Jersey.